Article Details
Retrieved on: 2021-09-18 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Celltrion's monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here